Peter Burkart

706 total citations
24 papers, 513 citations indexed

About

Peter Burkart is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Peter Burkart has authored 24 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 7 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in Peter Burkart's work include Chronic Lymphocytic Leukemia Research (5 papers), Blood groups and transfusion (5 papers) and Platelet Disorders and Treatments (3 papers). Peter Burkart is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Blood groups and transfusion (5 papers) and Platelet Disorders and Treatments (3 papers). Peter Burkart collaborates with scholars based in United States, Germany and South Africa. Peter Burkart's co-authors include Peter C. Holmberg, Kwan Y. Wong, Richard E. Rosenfield, William B. Scharfman, C. Cox, Zale P. Bernstein, Peter A. Kouides, Fred M. Howard, Shaul Kochwa and Katja Tecklenburg and has published in prestigious journals such as Journal of Biological Chemistry, The American Journal of Medicine and Transplantation.

In The Last Decade

Peter Burkart

24 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Burkart United States	13	285	105	73	72	51	24	513
Jan Säfwenberg Sweden	15	155 0.5×	44 0.4×	90 1.2×	69 1.0×	35 0.7×	29	806
Shilpa Jain United States	13	264 0.9×	181 1.7×	41 0.6×	91 1.3×	100 2.0×	26	583
J. Smith United States	9	76 0.3×	141 1.3×	38 0.5×	43 0.6×	93 1.8×	11	462
Santosh Kumar Gupta India	15	164 0.6×	75 0.7×	109 1.5×	151 2.1×	93 1.8×	54	739
S Bernasconi Italy	12	279 1.0×	90 0.9×	52 0.7×	47 0.7×	105 2.1×	42	618
Sarah E. Panzer United States	17	133 0.5×	61 0.6×	120 1.6×	62 0.9×	74 1.5×	46	721
Andrew Loughney United Kingdom	13	57 0.2×	70 0.7×	73 1.0×	16 0.2×	135 2.6×	24	513
Emily Barrow United States	12	352 1.2×	127 1.2×	68 0.9×	54 0.8×	59 1.2×	29	588
Matthew Frise United Kingdom	11	153 0.5×	102 1.0×	91 1.2×	28 0.4×	41 0.8×	20	462
JF Martin United States	10	133 0.5×	53 0.5×	66 0.9×	24 0.3×	50 1.0×	24	439

Countries citing papers authored by Peter Burkart

Since Specialization

Citations

This map shows the geographic impact of Peter Burkart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Burkart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Burkart more than expected).

Fields of papers citing papers by Peter Burkart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Burkart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Burkart. The network helps show where Peter Burkart may publish in the future.

Co-authorship network of co-authors of Peter Burkart

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Burkart. A scholar is included among the top collaborators of Peter Burkart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Burkart. Peter Burkart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Korinthenberg, Rudolf, et al.. (2007). Pharmacology, Efficacy, and Tolerability of Potassium Bromide in Childhood Epilepsy. Journal of Child Neurology. 22(4). 414–418. 27 indexed citations

Tecklenburg, Katja, Peter Burkart, Christian Hoser, Michael Rieger, & Christian Fink. (2006). Prospective Evaluation of Patellar Tendon Graft Fixation in Anterior Cruciate Ligament Reconstruction Comparing Composite Bioabsorbable and Allograft Interference Screws. Arthroscopy The Journal of Arthroscopic and Related Surgery. 22(9). 993–999. 40 indexed citations

Korinthenberg, Rudolf, et al.. (2004). 18FDG-PET in epilepsies of infantile onset with pharmacoresistant generalised tonic-clonic seizures. Epilepsy Research. 60(1). 53–61. 15 indexed citations

Difrancesco, Lisa, Peter Burkart, & James G. Hoehn. (2003). A Cutaneous Manifestation of Antiphospholipid Antibody Syndrome. Annals of Plastic Surgery. 51(5). 517–522. 10 indexed citations

Kouides, Peter A., Peter Burkart, C. Cox, et al.. (2000). Gynaecological and obstetrical morbidity in women with type I von Willebrand disease: results of a patient survey. Haemophilia. 6(6). 643–648. 148 indexed citations

Kouides, Peter A., Peter Burkart, Pradyumna D. Phatak, et al.. (1998). The substantial impact of von Willebrand disease on menstruation. Primary Care Update for OB/GYNS. 5(4). 153–154. 6 indexed citations

Nazeer, Tipu, Peter Burkart, Henry G. Dunn, Timothy A. Jennings, & Barbara C. Wolf. (1997). Blastic transformation of hairy cell leukemia.. PubMed. 121(7). 707–13. 8 indexed citations

Burkart, Peter, et al.. (1994). Superwarfarin poisoning: A significant public health problem. Journal of Community Health. 19(1). 55–65. 15 indexed citations

Burkart, Peter, et al.. (1994). In Vitro Effects of Hydroquinone, Benzoquinone, and Doxorubicin on Mouse and Human Bone Marrow Cells at Physiological Oxygen Partial Pressure. Toxicology and Applied Pharmacology. 129(1). 95–102. 12 indexed citations

10.

Scharfman, William B., et al.. (1993). Treatment of a patient with factor IX deficiency (hemophilia B) with coronary bypass surgery. Journal of Thoracic and Cardiovascular Surgery. 105(4). 765–766. 13 indexed citations

11.

Scharfman, William B., et al.. (1989). Granulocytic sarcoma: Three unusual patients. The American Journal of Medicine. 87(3). 345–347. 24 indexed citations

12.

Burkart, Peter, et al.. (1988). Platelet Transfusion Reaction Associated with Interdonor HLA Incompatibility¹. Vox Sanguinis. 55(3). 157–160. 28 indexed citations

13.

Burkart, Peter, et al.. (1988). Platelet Transfusion Reaction Associated withInterdonor HLA Incompatibility. Vox Sanguinis. 55(3). 157–160. 5 indexed citations

14.

Cassileth, Peter A., C B Begg, R Silber, et al.. (1987). Prolonged unmaintained remission after intensive consolidation therapy in adult acute nonlymphocytic leukemia.. PubMed. 71(2). 137–40. 35 indexed citations

15.

Yourno, Joseph, et al.. (1986). Monocyte nonspecific esterase. Enzymologic characterization of a neutral serine esterase associated with myeloid cells.. Journal of Histochemistry & Cytochemistry. 34(6). 727–733. 13 indexed citations

16.

Spiers, A. S. D., et al.. (1984). PHILADELPHIA CHROMOSOME: A RARE THREE‐WAY TRANSLOCATION IN ASSOCIATION WITH UNIQUE CLINICAL AND HAEMATOLOGICAL FEATURES. British Journal of Haematology. 56(2). 349–350. 1 indexed citations

17.

Burkart, Peter, et al.. (1979). IgM Cold‐Warm Hemolysins in Infectious Mononucleosis. Transfusion. 19(5). 535–538. 7 indexed citations

18.

Lam, Kwok‐Wai, Linda Lai, Peter Burkart, & L T Yam. (1977). Kinetic properties of tartrate-resistant acid phosphatase isolated from human spleen with leukemic reticuloendotheliosis.. Journal of Biological Chemistry. 252(10). 3371–3373. 6 indexed citations

19.

Rosenfield, Richard E., et al.. (1974). Instrumented PVP-Augmented Antiglobulin Tests. Vox Sanguinis. 26(4). 305–325. 1 indexed citations

20.

Burkart, Peter & Hilaire J. Meuwissen. (1973). IMMUNOCOMPETENT LYMPHOCYTES IN HUMAN AND PRIMATE MARROW. Transplantation. 16(4). 372–373. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact